Assessing the Impact of HPV Vaccination on Cervical Cancer Incidence: A Cross-Sectional Study
Received Date: Feb 01, 2025 / Published Date: Feb 27, 2025
Abstract
Human papillomavirus (HPV) vaccination has revolutionized cervical cancer prevention by reducing the incidence of high-risk HPV infections, which are the primary cause of cervical cancer. This study evaluates the impact of HPV vaccination on cervical cancer incidence through a cross-sectional analysis of epidemiological data. The findings highlight vaccination coverage, demographic variations, and the correlation between immunization rates and cancer trends. Understanding these dynamics is essential for optimizing vaccination programs, addressing disparities, and enhancing global cervical cancer prevention strategies.
Citation: Severo G (2025) Assessing the Impact of HPV Vaccination on Cervical Cancer Incidence: A Cross-Sectional Study. Cervical Cancer, 10: 256. Doi: 10.4172/2475-3173.1000256
Copyright: 漏 2025 Severo G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
天美传媒 Access Journals
Article Tools
Article Usage
- Total views: 641
- [From(publication date): 0-0 - Jan 01, 2026]
- Breakdown by view type
- HTML page views: 492
- PDF downloads: 149
